Cardiol Therapeutics (CRDL), a clinical-stage life sciences company, is researching and developing new drugs to fight inflammation and scarring in the heart. Their main drug, CardiolRx™, is b
Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
Structure Therapeutics is developing an oral weight-loss drug, which could allow it to gain traction in a rapidly expanding addressable market.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
The collaboration could help solve challenges for both businesses.
Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF?
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Discover the compelling stories behind three mega-cap dividend stocks that have caught the attention of analysts and investors alike.
Don't wait too long to invest in these exciting stocks.
It may not be too late to invest in this promising healthcare stock, even though it may look expensive.